Report title: Tongli Pharmaceuticals (USA), Inc.
from Datamonitor Company Profiles
12 page (1888 word) report published Sep 30, 2009

Price $100.00 available for immediate download
Report Overview
 
Search Inside
 
About Datamonitor Company Profiles

Abstract: Datamonitor's Tongli Pharmaceuticals (USA), Inc. Company Profile is the essential source for top-level company data and information. Tongli Pharmaceuticals (USA), Inc. Company Profile examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Tongli Pharmaceuticals (TP), through its wholly-owned subsidiary, Harbin Tianmu Pharmaceuticals Co., develops, produces and sells a variety of pharmaceuticals and healthcare products in the People's Republic of China that are based on traditional Chinese medicine, or traditional Chinese medicine (TCM). The company primarily operates in the US where it is headquartered in New York and employs around 86 people. The company recorded revenues of $7.4 million in the fiscal year ended March 2009, as compared to the revenues of $2 million in 2008. The company's operating profit was $2.1 million in fiscal 2009, as compared to an operating profit of $0.4 million in 2008. Its net profit was $1.9 million in fiscal 2009, as compared to the net profit of $0.3 million in 2008.

Scope of the Report

- Provides all the crucial information on Tongli Pharmaceuticals (USA), Inc. required for business and competitor intelligence needs
-Data is supplemented with details on Tongli Pharmaceuticals (USA), Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Tongli Pharmaceuticals (USA), Inc.

Reasons to Purchase

- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available


Brief Excerpt: ...Tongli Pharmaceuticals (TP), through its wholly-owned subsidiary, Harbin Tianmu Pharmaceuticals Co., develops, produces and sells a variety of pharmaceuticals and healthcare products in the People's Republic of China that are based on traditional Chinese medicine, or traditional Chinese medicine (TCM). The company primarily operates in the US where it is headquartered in New York and employs around 86 people. The company recorded revenues of $7.4 million in the fiscal year ended March 2009, as compared to the revenues of $2 million in 2008. The company's operating profit was $2.1 million in fiscal 2009, as compared to an operating profit of $0.4 million in 2008. Its net profit was $1.9 million in fiscal 2009, as compared to the net profit of $0.3 million in 2008....

Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $100.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.